Efficacy of moclobemide in burning mouth syndrome: a nonrandomized, open-label study.

To compare burning mouth syndrome (BMS) patients with age- and gender-matched controls for psychologic conditions, to analyze the effect of menstrual state on the intensity of burning, and to assess the efficacy of an antidepressant medication on the burning pain and psychologic status.
Ninety-four patients with BMS and 94 matched control subjects participated in the study. Anxiety and depression were analyzed by means of the Spielberger State-Trait Anxiety Inventory and Zung Self-Rating Depression Scale, and the severity of the burning sensation was measured by means of a visual analog scale (VAS). In female BMS patients and controls, the menstrual state was noted (menstruating, menopausal, or postmenopausal). BMS patients were treated with the antidepressant moclobemide (150 mg 2 times daily) for 3 months. Thereafter, anxiety, depression, and burning pain intensity were reassessed. Patient-perceived satisfactory improvement for burning sensation was assessed using a 5-point categorical rating of change scale.
BMS patients had significantly higher anxiety and depression scores than controls (P < .05). After treatment, anxiety and depression scores as well as the VAS values for burning pain decreased significantly (P < .001). Thirty-seven patients reported good to very good improvement, and 44 reported satisfactory improvement. No adverse reactions were reported.
The study confirmed earlier reports that BMS patients have higher anxiety and depression levels than controls. An antidepressant medication may be effective in alleviating the burning pain, at least in the short-term.
AuthorsFiliz Namdar Pekiner, Birsay Gumru, Semih Ozbayrak
JournalJournal of orofacial pain (J Orofac Pain) Vol. 22 Issue 2 Pg. 146-52 ( 2008) ISSN: 1064-6655 [Print] United States
PMID18548844 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Antidepressive Agents
  • Moclobemide
  • Analysis of Variance
  • Antidepressive Agents (therapeutic use)
  • Anxiety (complications, drug therapy)
  • Burning Mouth Syndrome (complications, drug therapy, physiopathology, psychology)
  • Case-Control Studies
  • Depression (complications, drug therapy)
  • Female
  • Humans
  • Male
  • Menstruation (physiology)
  • Moclobemide (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: